{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:12:25Z","timestamp":1769753545945,"version":"3.49.0"},"reference-count":41,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00122","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T03:46:39Z","timestamp":1489117599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Dissecting Target Toxic Tissue and Tissue Specific Responses of Irinotecan in Rats Using Metabolomics Approach"],"prefix":"10.3389","volume":"8","author":[{"given":"Yiran","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.chroma.2004.08.060","article-title":"Liquid chromatographic\u2013tandem mass spectrometric assay for the simultaneous quantification of Camptosar\u00ae and its metabolite SN-38 in mouse plasma and tissues.","volume":"1073","author":"Bardin","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"B2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1021\/pr9008223","article-title":"Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology.","volume":"9","author":"Bjerrum","year":"2010","journal-title":"J. Proteome Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity.","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3177\/jnsv.50.272","article-title":"Alleviation of fatty liver by. alpha-linolenic acid.","volume":"50","author":"Buang","year":"2004","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/10715769509147535","article-title":"Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients.","volume":"22","author":"Buffinton","year":"1995","journal-title":"Free Radic. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00280-014-2434-8","article-title":"Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model.","volume":"74","author":"Costa","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.bi.44.070175.001313","article-title":"Bile acid metabolism.","volume":"44","author":"Danielsson","year":"1975","journal-title":"Annu. Rev. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.taap.2015.12.003","article-title":"Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression.","volume":"291","author":"Fang","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.bjc.6690364","article-title":"CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues.","volume":"80","author":"Guichard","year":"1999","journal-title":"Br. J. Cancer"},{"key":"B10","first-page":"3723","article-title":"Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.","volume":"54","author":"Gupta","year":"1994","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bcp.2010.09.001","article-title":"Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.","volume":"81","author":"Hatfield","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"B12","first-page":"1189","article-title":"Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.","volume":"60","author":"Humerickhouse","year":"2000","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1007\/s00595-011-4546-7","article-title":"Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer.","volume":"41","author":"Ikeguchi","year":"2011","journal-title":"Surg. Today"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1021\/pr3003529","article-title":"Metabonomic analysis reveals the CCl4-induced systems alterations for multiple rat organs.","volume":"11","author":"Jiang","year":"2012","journal-title":"J. Proteome Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1096-8652(200101)66:146::AID-AJH10073.0.CO;2-O","article-title":"\u201cLiver function tests\u201d are not always tests of liver function.","volume":"66","author":"Korones","year":"2001","journal-title":"Am. J. Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.","volume":"268","author":"Lake","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"45ra59","key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001270","article-title":"The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.","volume":"2","author":"Lam","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/ibd.21502","article-title":"Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers.","volume":"17","author":"Lenicek","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00280-011-1780-z","article-title":"Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.","volume":"69","author":"Lima-J\u00fanior","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"e39764","key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039764","article-title":"Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS ONE"},{"key":"B21","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).","volume":"7","author":"Mathijssen","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.critrevonc.2013.05.011","article-title":"Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: a review of mechanisms and outcomes.","volume":"88","author":"McWhirter","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jss.2010.10.003","article-title":"Irinotecan injures tight junction and causes bacterial translocation in rat.","volume":"173","author":"Nakao","year":"2012","journal-title":"J. Surg. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0016-5085(95)90344-5","article-title":"Dietary saturated fatty acids: a novel treatment for alcoholic liver disease.","volume":"109","author":"Nanji","year":"1995","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000199893","article-title":"Effects of dietary linoleic acid on mucosal adaptation after small bowel resection.","volume":"44","author":"Park","year":"1989","journal-title":"Digestion"},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria.","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet.","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1111\/bph.12719","article-title":"Interleukin-18 as a target for modulation of irinotecan-induced intestinal toxicity: a step towards a better therapeutic index?: Commentary on Lima-Junior et al., Br. J. Pharmacol. 171: 2335\u20132350.","volume":"172","author":"Spyropoulos","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B29","first-page":"3752","article-title":"Involvement of \u03b2-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.","volume":"56","author":"Takasuna","year":"1996","journal-title":"Cancer Res."},{"key":"B30","first-page":"5778","article-title":"Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11.","volume":"62","author":"Trifan","year":"2002","journal-title":"Cancer Res."},{"issue":"142","key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-7-142","article-title":"Centering, scaling, and transformations: improving the biological information content of metabolomics data.","volume":"7","author":"van den Berg","year":"2006","journal-title":"BMC Genomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1139\/o85-108","article-title":"The role of phosphatidylcholine biosynthesis in the secretion of lipoproteins from hepatocytes.","volume":"63","author":"Vance","year":"1985","journal-title":"Can. J. Biochem. Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity.","volume":"183","author":"Vavassori","year":"2009","journal-title":"J. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide.","volume":"67","author":"Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.freeradbiomed.2004.06.033","article-title":"Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.","volume":"37","author":"Videla","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"38","key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-38","article-title":"Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.","volume":"4","author":"Wang","year":"2011","journal-title":"BMC Med. Genomics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"26420","DOI":"10.1039\/C5RA02581H","article-title":"Metabolomic study of Chinese medicine Huang Qin decoction as an effective treatment for irinotecan-induced gastrointestinal toxicity.","volume":"5","author":"Wang","year":"2015","journal-title":"RSC Advances"},{"issue":"20","key":"B38","article-title":"Analysis of fatty acids composition in the liver of mice with non-alcoholic fatty liver disease.","volume":"17","author":"Wang","year":"2011","journal-title":"Sci. Agric. Sin."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1021\/ac701988a","article-title":"Magic angle spinning NMR and 1H-31P heteronuclear statistical total correlation spectroscopy of intact human gut biopsies.","volume":"80","author":"Wang","year":"2008","journal-title":"Anal. Chem."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.","volume":"263","author":"Yao","year":"1988","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1096\/fasebj.3.7.2469614","article-title":"Lipid regulation of cell membrane structure and function.","volume":"3","author":"Yeagle","year":"1989","journal-title":"FASEB J."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T20:58:04Z","timestamp":1658782684000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":41,"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00122","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}